GL1X · GenesisL1 explorer

MolNFT v1 · #172177 · protein

Crystal structure of human brachyury G177D variant in complex with afatinib

6ZU8 · Brachyury protein: “Crystal structure of human brachyury G177D variant in complex with afatinib”. X-ray diffraction, 2 ligands (0WN, ZN), 1 pocket (best druggability 0.49). MolNFT v1 #172177 on GenesisL1: 3D structure, binding sites…

PDB
6ZU8
Type
protein
Length
179 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Brachyury protein
UniProt
O15178
Ligands
0WN, ZN
Pockets
1 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABrachyury proteinprotein17918% helix, 37% strandO15178

Ligands and binding sites

  • 0WN · N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)butanamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11740.490.7719empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6ZU8 · Crystal structure of human Brachyury G177D variant in complex with Afatinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.